Literature DB >> 1443713

Thermoregulatory vasoconstriction during propofol/nitrous oxide anesthesia in humans: threshold and oxyhemoglobin saturation.

J M Hynson1, D I Sessler, K Belani, D Washington, J McGuire, B Merrifield, M Schroeder, A Moayeri, D Crankshaw, S Hudson.   

Abstract

To determine the thermoregulatory effects of propofol and nitrous oxide, we measured the threshold for peripheral vasoconstriction in seven volunteers over a total of 13 study days. We also evaluated the effect of vasoconstriction on oxyhemoglobin saturation (SpO2). Anesthesia was induced with an intravenous bolus dose of propofol (2 mg/kg), followed by an infusion of 180 micrograms.kg-1 x min-1 for 15 min, and maintained with 60% nitrous oxide and propofol (80-160 micrograms.kg-1 x min-1). Central and skin surface temperatures and SpO2 (using two different pulse oximeters) were measured continuously; plasma propofol concentrations and arterial PO2 were measured at 15-min intervals. Volunteers were cooled with a circulating water blanket until definitive peripheral vasoconstriction was detected. The tympanic membrane temperature triggering vasoconstriction was considered the thermoregulatory threshold. Vasoconstriction developed on seven study days during propofol/nitrous oxide anesthesia at a central temperature of 33.3 +/- 1.0 degrees C (mean +/- SD) and plasma propofol concentration of 3.9 +/- 1.1 micrograms/mL. The thresholds during anesthesia were significantly lower than those during the control period (36.7 +/- 0.3 degrees C), but the correlation between plasma propofol concentrations and vasoconstriction thresholds was poor. On the remaining six study days, vasoconstriction did not develop despite central temperatures ranging from 32.1 to 32.7 degrees C. Corresponding propofol concentrations were 4.1-10.9 micrograms/mL. These data suggest that anesthesia with propofol, in typical clinical concentrations, and 60% nitrous oxide substantially inhibits thermoregulatory vasoconstriction. Vasoconstriction increased SpO2 by approximately 2% without a significant concomitant change in PO2. The observed increase in SpO2 probably reflects decreased transmission of arterial pulsations to venous blood in the finger.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443713     DOI: 10.1213/00000539-199212000-00013

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Effect of peripheral vasoconstriction on pulse oximetry.

Authors:  Pekka Talke; Claudia Stapelfeldt
Journal:  J Clin Monit Comput       Date:  2006-07-14       Impact factor: 2.502

Review 2.  Pulse oximetry: fundamentals and technology update.

Authors:  Meir Nitzan; Ayal Romem; Robert Koppel
Journal:  Med Devices (Auckl)       Date:  2014-07-08

3.  Comparison of forehead and finger oximetry sensors during the six minute walk test.

Authors:  Lucy Robertson; Rachel Lowry; Karl Sylvester; Helen Parfrey; Beverley Moseley; Karen Sheares; Katrina Oates
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 2.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.